Abigail Mawer

• Generics
• Health Policy and Regulation
• Healthcare Delivery
• Market Access
• Policy Analysis
• R&D Incentives
• Biosimilars
• Drug Development/R&D
• Health Care Systems
• Health Data and Statistics
• Use of Medicines

The Dynamics of Drug Shortages

Read more

• Australia
• Canada
• Denmark
• England
• France
• Gene therapies
• Germany
• HTA
• Italy
• Spain
• Sweden
• Switzerland
• The Netherlands
• Cell and Gene Therapies
• Health Technology Assessment…

Are Recommendations for HTA of Gene Therapies Being Achieved?

Read more

• Asia
• HTA
• Pricing and Reimbursement
• South Korea
• Taiwan
• Health Technology Assessment…
• Real World Evidence (RWE)

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Read more

• Cell and Gene Therapies

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Read more

• Cancer Research UK
• Innovation
• NHS
• Oncology
• Pricing and Reimbursement
• UK
• Health Care Systems
• Real World Evidence (RWE)
• Value-Based Pricing

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

Read more